E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/28/2021 in the Prospect News Structured Products Daily.

New Issue: JPMorgan sells $6.6 million yield notes on Merck

By Kiku Steinfeld

Chicago, May 28 – JPMorgan Chase Financial Co. LLC priced $6.6 million of 6.8% yield notes due May 4, 2022 linked to the common stock of Merck & Co., Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by JPMorgan Chase & Co.

Interest is payable quarterly.

The payout at maturity will be par unless the stock finishes below its initial value and has closed below the 80% trigger level on any day during the life of the notes, in which case investors will be fully exposed to the stock’s decline.

J.P. Morgan Securities LLC is the agent.

Issuer:JPMorgan Chase Financial Co. LLC
Guarantor:JPMorgan Chase & Co.
Issue:Yield notes
Underlying stock:Merck & Co., Inc.
Amount:$6,595,000
Maturity:May 4, 2022
Coupon:6.8%, payable quarterly
Price:Par
Payout at maturity:Par unless stock finishes below initial value and has ever closed below trigger value during life of notes, in which case full exposure to losses
Initial value:$73.17
Trigger value:$58.536; 80% of initial value
Strike date:April 29
Pricing date:April 30
Settlement date:May 5
Agent:J.P. Morgan Securities LLC
Fees:0.10633%
Cusip:48132T6F8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.